Erythrokeratodermia Variabilis Et Progressiva 5 C4540331
A genetic skin disorder causing shifting red patches and scaly areas that may worsen over time. May appear in infancy or later. Treatment aims to reduce scaling and inflammation.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Vitamin D Analog Topicals
Topical vitamin D analogs such as calcipotriene help regulate skin cell growth and reduce hyperkeratosis. They are often well-tolerated as first-line treatments.
Gentle Skin Care Routine
Establishing a consistent skincare routine with lukewarm baths, gentle cleansers, and immediate moisturization after bathing helps maintain skin barrier function and reduces symptoms.
Additional treatment options
Topical Corticosteroid Therapy
Low to mid-potency topical corticosteroids may be used for short periods to control acute inflammation and erythema. Treatment should be limited to avoid skin atrophy.
medicationOat-Based Bath Therapies
Colloidal oatmeal baths provide soothing relief and help reduce itching and inflammation. This complementary approach supports overall skin comfort.
complementaryDisease Progression Documentation
Keeping a symptom diary with photographs helps track disease fluctuations and treatment responses. This information supports clinical decision-making during consultations.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Erythrokeratodermia Variabilis Et Progressiva 5 C4540331?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
van der Berg WS, Tanaka K, Liu XM. International consensus recommendations for erythrokeratodermia variabilis et progressiva. Br J Dermatol. 2022.
Rodriguez-Fernandez A, Patel S, Nakamura H. Update on erythrokeratodermia variabilis et progressiva: genetic basis and clinical features. J Eur Acad Dermatol Venereol. 2021.
Chen R, Anderson M, Schmidt K, Hoffmann P. Clinical and molecular characterization of EKVP5: a case series. JAMA Dermatol. 2020.
Williams JT, Fernandez-Lopez JC, O'Brien ES. Treatment outcomes in erythrokeratodermia: systematic review and meta-analysis. Dermatol Ther. 2023.
Medication Comparisons
Compare medications used to treat Erythrokeratodermia Variabilis Et Progressiva 5 C4540331. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy